Related Experiment Video
Updated: Jun 22, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
[Treatment of insomnia]
Ulrich Michael Hemmeter1, Andreas Thum
1Kantonale Psychiatrische Dienste St. Gallen-Nord, Center of Education and Research (COEUR), und Klinik für Psychiatrie und Psychotherapie, Philipps-Universität Marburg/D. ulrich.hemmeter@gd-kpdw.sg.ch
Insomnia affects up to 35% of people in Western countries, impairing cognitive and mood functions. Treatment prioritizes non-pharmacological methods, with limited use of non-benzodiazepine hypnotics and caution regarding benzodiazepines.
Area of Science:
- Sleep Medicine
- Neuroscience
- Public Health
Context:
- High prevalence of insomnia (up to 35%) in Western industrial countries.
- Sleep disturbances significantly impact cognitive functions, mood, and metabolism.
- Accurate diagnosis and characterization of insomnia are crucial.
Purpose:
- To outline diagnostic importance and treatment strategies for insomnia.
- To emphasize non-pharmacological interventions before symptomatic treatment.
- To review efficacious pharmacological options and contraindications.
Summary:
- Treatment is etiology and intensity-dependent; secondary insomnia requires addressing the underlying cause.
- Non-pharmacological interventions are recommended prior to pharmacological treatment.
- Short-term use of non-benzodiazepine hypnotics is effective; longer-term options include hypnotic antidepressants/neuroleptics, avoiding anticholinergic effects.
Impact:
- Informed clinical decision-making for insomnia management.
- Reduced reliance on potentially harmful long-term hypnotic medications.
- Improved patient outcomes through targeted and safe insomnia treatment strategies.
More Related Videos
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...